GENE

GENE Company Financials

$0.346
*  
0.013
3.62%
Get GENE Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading GENE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks


Annual Income Statement (values in 000's) Get Quarterly Data

Period Ending: Trend 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Net Income
($9,565) ($8,558) ($5,430) $965
Cash Flows-Operating Activities
Depreciation
$0 $0 $0 $0
Net Income Adjustments
$0 $0 $0 $0
Changes in Operating Activities
Accounts Receivable
$0 $0 $0 $0
Changes in Inventories
$0 $0 $0 $0
Other Operating Activities
$0 $0 $0 $0
Liabilities
$0 $0 $0 $0
Net Cash Flow-Operating
($10,370) ($6,881) ($7,866) $2,391
Cash Flows-Investing Activities
Capital Expenditures
($45) ($49) ($78) ($150)
Investments
($173) ($159) $550 $0
Other Investing Activities
$437 $44 $32 $155
Net Cash Flows-Investing
$219 ($164) $505 $5
Cash Flows-Financing Activities
Sale and Purchase of Stock
$5,985 $417 $11,175 $0
Net Borrowings
$5,268 ($16) ($52) ($337)
Other Financing Activities
$0 $0 $0 $0
Net Cash Flows-Financing
$11,253 $401 $11,123 ($337)
Effect of Exchange Rate
($55) $72 $130 ($134)
Net Cash Flow
$1,103 ($6,643) $3,761 $2,059

See also: Company Financials data entry page